Clovis Oncology — innovating cancer drugs through precision medicine.
Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Their development programs are targeted at specific subsets of cancer, combining precision medicine with companion diagnostics to direct therapeutics to those patients most likely to benefit from them.
They have one marketed product: Rubraca® (rucaparib) tablets, and are currently in active development for rucaparib, an oral tablet for the treatment of ovarian cancer.
Learn more on their website >